JP Patent

JP6389177B2 — オランザピンハプテンに対する抗体及びその使用

Assigned to ヤンセン ファーマシューティカ エヌ.ベー. · Expires 2018-09-12 · 8y expired

What this patent protects

Patent listed against zoliflodacin.

Drugs covered by this patent

Patent Metadata

Patent number
JP6389177B2
Jurisdiction
JP
Classification
Expires
2018-09-12
Drug substance claim
No
Drug product claim
No
Assignee
ヤンセン ファーマシューティカ エヌ.ベー.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.